Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study
Titel:
Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study
Auteur:
Erdes, Sh. Mazurov, V. I. Gaydukova, I. Z. Anoshenkova, O. N. Vinogradova, I. B. Grabovetskaya, Yu. Yu. Davidian, S. Y. Kiryukhina, N. A. Epifanova, O. E. Masneva, L. V. Menshikova, L. V. Mironenko, O. N. Nikulenkova, N. E. Povarova, T. V. Poliatika, A. N. Samigullina, R. R. Sizikov, A. E. Totrov, I. N. Umnova, I. F. Usacheva, J. V. Chudinov, A. L.